US Stocks
/
Ligand Pharmaceuticals Incorporated Share Price

Ligand Pharmaceuticals Incorporated Share Price

NASDAQ: LGND | Mid Cap
$295.42
+$1.68 (0.57%) Last updated on 09 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Ligand Pharmaceuticals Incorporated Stock Performance

Open
$288.92
Prev. Close
$293.75
Circuit Range
N/A
Day Range
$283.11 - $294.75
Year Range
$176.10 - $323.51
Volume
31,978
Average Traded
$292.37

Ligand Pharmaceuticals Incorporated Share Price Today

As of 9 October 2026, Ligand Pharmaceuticals Incorporated's share price is $295.42. The stock opened at $288.92, compared to its previous close of $293.75. During today's trading session, Ligand Pharmaceuticals Incorporated's share price traded between $283.11 and $294.75, with an average price of $288.93. Over the past 52 weeks, the stock has recorded a high of $323.51 and a low of $176.10. In terms of performance, Ligand Pharmaceuticals Incorporated's share price has risen by 28.88% over the last six months and is up 53.72% on a year-on-year basis.

Ligand Pharmaceuticals Incorporated Share Price Chart

$283.11$294.75
L
Show Current Price
H

Ligand Pharmaceuticals Incorporated Stock Fundamentals & Key Indicators

Market Cap
$5.71B
PE Ratio (TTM)
29.82
Dividend Yield
0.00%
EPS (TTM)
$9.89
Revenue (TTM)
$268.09B
Return On Equity (TTM)
20.38%
Profit Margin
46.42%
Debt to Equity
1.16
Quarterly Earnings Growth YoY
-58.63%

Ligand Pharmaceuticals Incorporated Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$115.46$59.67$51.72$63.69
Net Profit$117.27$44.78-$13.35$48.51
Net Profit Margin101.57%75.05%-25.81%76.17%
Income ChangeN/A-61.81%-129.81%463.37%

Ligand Pharmaceuticals Incorporated Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$196.25$131.31$167.13$268.09
Net Profit-$33.36$52.15-$4.03$124.45
Net Profit Margin-17.00%39.72%-2.41%46.42%
Income ChangeN/A256.32%-107.73%3188.09%

About Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

Ligand Pharmaceuticals Incorporated Historical Returns

MonthOpenCloseChange %
Oct 2026
$310.84
$294.74
-5.77%
Sep 2026
$285.38
$312.78
+9.99%
Aug 2026
$287.36
$284.37
-1.10%
Jul 2026
$309.34
$287.54
-8.97%
Jun 2026
$227.40
$315.86
+36.19%
May 2026
$227.63
$231.93
+1.18%
Apr 2026
$204.59
$229.22
+14.70%
Mar 2026
$199.41
$199.84
+0.68%
Feb 2026
$197.65
$198.50
+3.31%
Jan 2026
$189.97
$192.14
+1.60%
Dec 2025
$199.78
$189.11
-6.70%
Nov 2025
$191.59
$202.70
+5.47%

LGND Share Price FAQs

What is Ligand Pharmaceuticals Incorporated share price today?

chevron-up
Ligand Pharmaceuticals Incorporated share price today is $295.42 as on October 9, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Ligand Pharmaceuticals Incorporated stock?

chevron-up
The 52 week high of Ligand Pharmaceuticals Incorporated stock is $323.51, while the 52 week low is $176.10 as of 9 Oct '26.

What is LGND's market capitalisation today?

chevron-up
LGND market capitalisation is $5.71B as of October 9, 2026, at 3:01 pm IST.

What is LGND's net income for the last quarter?

chevron-up
LGND's net income for the last quarter is 48.51B USD.

What is the 5 year returns of LGND?

chevron-up
The 5 year returns of LGND is 102.43% as on 9 Oct '26.

What is the high & low stock price of LGND today?

chevron-up
LGND stock price hit a high of $294.75 and low of $283.11 as of 9 Oct '26.

Can I buy LGND shares in India?

chevron-up
Yes. You can buy LGND in India by opening an international trading account.